Kairos Pharma, Ltd. (KAPA)

Kairos Pharma Ltd. announces a peer-reviewed publication highlighting a potential breakthrough in overcoming drug resistance in non-small cell lung cancer. A social media post mentions KAPA alongside other trending tickers, indicating recent community interest.

About Kairos Pharma, Ltd.

Kairos Pharma, Ltd. (KAPA) is a cryptocurrency token focused on therapeutic programs and patient impact.
Kairos Pharma, Ltd. uses the ticker $KAPA for trading. Listed in the Stocks category.

Insights

Kairos Pharma, Ltd. (KAPA) social dominance is up 256% from the previous week.
Kairos Pharma, Ltd. (KAPA) creators is up 21.28% from the previous week.
Kairos Pharma, Ltd. (KAPA) engagements is up 7765.61% from the previous month.
Kairos Pharma, Ltd. (KAPA) mentions is up 37.97% from the previous week.
Kairos Pharma, Ltd. (KAPA) posts created is up 150% from the previous week.
Kairos Pharma, Ltd. Galaxy Score™ hit a 52-Week high of [--] for the hour
Kairos Pharma, Ltd. Galaxy Score™ hit an all time of [--] for the hour

Price: $0.598

Price 24-Hour Time-Series Raw Data
The price of KAPA has hit a 52-week high, driven by a significant increase in social dominance and engagements, suggesting positive social sentiment and community activity are the primary factors behind the current price surge.

24-Hour: -0.33% 7-Day: -7.46% 30-Day: -31.47%

1-Year High: $2 on 2025-09-09
1-Year Low: $0.473 on 2025-06-06

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Kairos Pharma, Ltd. (KAPA) is currently AltRank #1,632 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-02-18
1-Year Low: [--] on 2026-01-30

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +289%
[--] Month: [-------] +7,766%
[--] Months: [---------] -46%
[--] Year: [---------] +110%
1-Year High: [-------] on 2026-01-25
1-Year Low: [--] on 2026-01-05

Engagements by network (24h): News: [---] X: [---] YouTube: [--] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +38%
1-Year High: [-----] on 2025-07-22
1-Year Low: [--] on 2025-12-28

Mentions by network (24h): News: [--] X: [--] YouTube: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Kairos Pharma, Ltd. (KAPA) in the last [--] hours which is down 13% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +21%
1-Year High: [---] on 2025-07-18
1-Year Low: [--] on 2025-12-28

The most influential creators that mention Kairos Pharma, Ltd. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@rabeaeee800	[--]	[--]	[--]	[---]
@tasi53525	[--]	[---]	[--]	[---]
@Roqaya939738	[--]	[---]	[--]	[---]
@ayasalmny	[--]	[--]	[--]	[--]
@BuyTheUgly	[--]	[--]	[--]	[--]
@stocket_rocket	[--]	[--]	[--]	[--]
@ib24059210	[--]	[--]	[--]	[--]
@KairosPharma	[--]	[---]	[--]	[--]
@LayanAhmed5637	[--]	[--]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 91%
[--] Week: 100% no change
[--] Month: 100% no change
[--] Months: 100% +5%
[--] Year: 100% no change
1-Year High: 100% on 2025-02-18
1-Year Low: 33% on 2025-12-30

Most Supportive Themes:

Increased Social Engagement: (75%) A significant surge in social media interactions and mentions indicates growing community interest and positive sentiment.
Positive Sentiment: (90%) Overwhelmingly positive sentiment surrounding Kairos Pharma, Ltd. (KAPA) suggests strong community confidence in its therapeutic programs and patient impact.

Most Critical Themes:

Decreased Creator Activity: (25%) A notable drop in active social media creators mentioning KAPA could signal a temporary lull in content generation or a shift in influencer focus.
Low Market Dominance: (0.000015669662470686894%) While social metrics are strong, KAPA's market dominance remains extremely low, indicating limited impact on the broader cryptocurrency market.

Social Dominance: 0.00363%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00363%
Daily Average: 0.00832%
[--] Week: 0.00356% +0.00256%
[--] Month: 0.0036% +0.0017%
[--] Months: 0.0036% -0.0043%
[--] Year: 0.0036% -0.0036%
1-Year High: 0.167% on 2025-07-22
1-Year Low: 0.0001% on 2025-12-28

Market Dominance: 0.000014425105042553425%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.000014425105042553425%
Daily Average: 0%
1-Year High: 0.00002% on 2026-01-13
1-Year Low: 0.00001% on 2026-02-05

Market Cap: $12,734,339

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $12,734,339
Daily Average: $14,821,204
[--] Week: $12,734,339 -4.40%
[--] Month: $12,451,169 -31%
1-Year High: $18,531,004 on 2026-01-15
1-Year Low: $12,284,598 on 2026-02-05

Top Kairos Pharma, Ltd. News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

"Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer LOS ANGELES March [--] 2025--Kairos Pharma Ltd. (NYSE American: KAPA) a clinical-stage biopharmaceutical company announces a peer-reviewed publication highlighting a potentially significant breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small cell lung cancer (NSCLC) patients. Recent findings published in Drug Resistance Updates highlight the critical role of CD105 (endoglin) in mediating resistance to"
News Link @YahooFinance 2025-03-20T11:38Z 2M followers, 236K engagements

Top Kairos Pharma, Ltd. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"👌 $SMCI/ $SONN / $TGTX/ $KAPA 💥👌 $SPX $LCID $BTS $NVDA $TSLA $NCNA $HIMS $MULN $HOLO $PHH $ABVE $GNS $HOTH $SMCI $RXRX $FLNC $CENN $PTHL $NAOV $RKLB $YOUL $META"
X Link @rabeaeee800 2026-02-15T21:31Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing